Comparative Study of Voxel-Based Epileptic Foci Localization Accuracy between Statistical Parametric Mapping and Three-dimensional Stereotactic Surface Projection

Introduction Fluorine-18-fluorodeoxyglucose positron-emission tomography (18F-FDG-PET) is widely used to help localize the hypometabolic epileptogenic focus for presurgical evaluation of drug-refractory epilepsy patients. Two voxel-based brain mapping methods to interpret 18F-FDG-PET, statistical parametric mapping (SPM) and three-dimensional stereotactic surface projection (3D-SSP), improve the detection rate of seizure foci. This study aimed to compare the consistency of epileptic focus detection between SPM and 3D-SSP for 18F-FDG-PET brain mapping analysis. Methods We retrospectively reviewed the clinical, electroecephalographic, and brain imaging results of 35 patients with refractory epilepsy. 18F-FDG-PET studies were revaluated by SPM, 3D-SSP, and visual assessment, and the results were compared to the magnetic resonance imaging (MRI) lesion location and to the presumed epileptogenic zone (PEZ) defined by video-electroencephalogram and other clinical data. A second consistency study compared PET analyses to histopathology and surgical outcomes in the 19 patients who underwent lesion resection surgery. Results Of the 35 patients, consistency with the PEZ was 29/35 for SPM, 25/35 for 3D-SSP, 14/35 for visual assessment, and 10/35 for MRI. Concordance rates with the PEZ were significantly higher for SPM and 3D-SSP than for MRI (P < 0.05) and visual assessment (P < 0.05). Differences between SPM and 3D-SSP and between visual assessment and MRI were not significant. In the 19 surgical patients, concordance with histopathology/clinical outcome was 14/19 for SPM, 15/19 for 3D-SSP, 14/19 for visual assessment, and 9/19 for MRI (P > 0.05). A favorable Engel outcome (class I/II) was found in 16 of 19 cases (84%), and failure of seizure control was found in 3 of 19 patients (class III/IV). Conclusion Voxel-based 18F-FDG-PET brain mapping analysis using SPM or 3D-SSP can improve the detection rate of the epileptic focus compared to visual assessment and MRI. Consistency with PEZ was similar between SPM and 3D-SSP; according to their own characteristics, 3D-SSP is recommended for primary evaluation due to greater efficiency and operability of the software, while SPM is recommended for high-accuracy localization of complex lesions. Therefore, joint application of both software packages may be the best solution for FDG-PET analysis of epileptic focus localization.

[1]  A. Drzezga,et al.  Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  Kengo Ito,et al.  Computer-assisted system for diagnosing degenerative dementia using cerebral blood flow SPECT and 3D-SSP: a multicenter study , 2014, Japanese Journal of Radiology.

[3]  R. Petersen,et al.  Visual Assessment Versus Quantitative Three-Dimensional Stereotactic Surface Projection Fluorodeoxyglucose Positron Emission Tomography for Detection of Mild Cognitive Impairment and Alzheimer Disease , 2012, Clinical nuclear medicine.

[4]  Tadashi Nariai,et al.  Voxel- and ROI-based statistical analyses of PET parameters for guidance in the surgical treatment of intractable mesial temporal lobe epilepsy , 2008, Annals of nuclear medicine.

[5]  N. Costes,et al.  Voxel-Based Analysis of Asymmetry Index Maps Increases the Specificity of 18F-MPPF PET Abnormalities for Localizing the Epileptogenic Zone in Temporal Lobe Epilepsies , 2010, Journal of Nuclear Medicine.

[6]  E. Reiman,et al.  Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias , 2008, Journal of Nuclear Medicine.

[7]  Jeffrey R. Tenney,et al.  Cerebral glucose hypometabolism is associated with mitochondrial dysfunction in patients with intractable epilepsy and cortical dysplasia , 2014, Epilepsia.

[8]  J. Czaplicki Synthesis of data , 2014 .

[9]  K. Ohtomo,et al.  Usefulness of extent analysis for statistical parametric mapping with asymmetry index using inter-ictal FGD-PET in mesial temporal lobe epilepsy , 2012, Annals of Nuclear Medicine.

[10]  G. Mathern,et al.  Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies , 2009, Epilepsia.

[11]  Giuseppe Tradigo,et al.  Methodologies for the analysis and classification of PET neuroimages , 2013, Network Modeling Analysis in Health Informatics and Bioinformatics.

[12]  Lennart Thurfjell,et al.  Visualization and Quantification of 3-Dimensional Stereotactic Surface Projections for 18F-Flutemetamol PET Using Variable Depth , 2016, The Journal of Nuclear Medicine.

[13]  Ken Thomas,et al.  Rapid Quantitative Analysis of Individual (18)FDG-PET Scans. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[14]  S. Ourselin,et al.  Brain imaging in the assessment for epilepsy surgery , 2016, The Lancet Neurology.

[15]  Stephan U Schuele,et al.  Intractable epilepsy: management and therapeutic alternatives , 2008, The Lancet Neurology.

[16]  K. Ishii,et al.  Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  Karl J. Friston,et al.  Rapid Assessment of Regional Cerebral Metabolic Abnormalities in Single Subjects with Quantitative and Nonquantitative [18F]FDG PET: A Clinical Validation of Statistical Parametric Mapping , 1999, NeuroImage.

[18]  F. Bartolomei,et al.  Resting cortical PET metabolic changes in psychogenic non-epileptic seizures (PNES) , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  M. Brodie,et al.  Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies , 2011 .

[20]  V. Mathews,et al.  Assessment and cost comparison of sleep-deprived EEG, MRI and PET in the prediction of surgical treatment for epilepsy , 2002, Seizure.

[21]  P. Garzone,et al.  Alzheimer’s Disease and Other Dementias , 2020, Acupuncture for Brain.

[22]  K. Byth,et al.  The topography and significance of extratemporal hypometabolism in refractory mesial temporal lobe epilepsy examined by FDG‐PET , 2010, Epilepsia.

[23]  W T Blume,et al.  Proposal for a New Classification of Outcome with Respect to Epileptic Seizures Following Epilepsy Surgery , 2001, Epilepsia.

[24]  K. Ishii,et al.  Fully automatic diagnostic system for early- and late-onset mild Alzheimer’s disease using FDG PET and 3D-SSP , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  S. Reuss,et al.  Construction and comparative evaluation of different activity detection methods in brain FDG-PET , 2015, Biomedical engineering online.

[26]  Josemir W Sander,et al.  Surgical treatment for epilepsy: the potential gap between evidence and practice , 2016, The Lancet Neurology.

[27]  Dong Soo Lee,et al.  Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  R. Koeppe,et al.  A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  O. Snead,et al.  The Utility of Positron Emission Tomography in Epilepsy , 2015, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[30]  O. Commowick,et al.  Voxel-Based Quantitative Analysis of Brain Images From 18F-FDG PET With a Block-Matching Algorithm for Spatial Normalization , 2012, Clinical nuclear medicine.

[31]  Dong Soo Lee,et al.  (18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  John S. Duncan,et al.  Selecting patients for epilepsy surgery: Synthesis of data , 2011, Epilepsy & Behavior.

[33]  Otto Muzik,et al.  Objective Detection of Epileptic Foci by 18F-FDG PET in Children Undergoing Epilepsy Surgery , 2010, The Journal of Nuclear Medicine.

[34]  D J Brooks,et al.  Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission , 2000, Neurology.

[35]  H. Fukuyama,et al.  Improved cerebral function in mesial temporal lobe epilepsy after subtemporal amygdalohippocampectomy. , 2009, Brain : a journal of neurology.

[36]  F. Dubeau,et al.  Invasive Electrographic Recording Techniques in Temporal Lobe Epilepsy , 2000, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[37]  H. Matsuda,et al.  Comparison of SPM and NEUROSTAT in voxelwise statistical analysis of brain SPECT and MRI at the early stage of Alzheimer’s disease , 2008, Annals of nuclear medicine.

[38]  M. Duchowny,et al.  PET hypermetabolism in medically resistant childhood epilepsy: Incidence, associations, and surgical outcome , 2016, Epilepsia.